•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) announced that its peripheral disposable support catheter Vericor has received marketing approval from the National Medical Products Administration (NMPA). The device is designed for peripheral vascular surgery, aiding in lesion access and treatment. Product ProfileSupport catheters are essential tools in peripheral vascular procedures,…
•
Acotec Scientific Holdings Ltd (HKG: 6669) has announced that its Vericor-S2 coronary microcatheter has received registration approval from the National Medical Products Administration (NMPA). The product is designed for use in percutaneous coronary interventions, specifically for guiding guidewires through narrow vessel lesions and providing a channel for saline or contrast…
•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its AcoArt Camellia, a paclitaxel-releasing coronary balloon dilation catheter. This medical device is now approved for the treatment of primary coronary artery disease in patients with vessel…
•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its thrombus aspiration catheter special support tube. This product is designed to assist in the delivery and placement of interventional instruments during peripheral vascular intervention surgery. Enhancing…
•
Acotec Scientific Holdings Ltd (HKG: 6669), based in China, has received marketing approval from the National Medical Products Administration (NMPA) for its Acotrace, a disposable catheter sheath group. The Acotrace is designed for the insertion of medical devices, including guide wires and catheters, into blood vessels, facilitating percutaneous puncture access…
•
Acotec Scientific Holdings Ltd (HKG: 6669), a leading medical device company based in China, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its product RunFlow, a heart valve balloon dilation catheter. Designed for autologous valve dilation of the aorta during artificial aortic…
•
Acotec Scientific Holdings Ltd (HKG: 6669), a leading medical device company based in China, has announced that it has received separate marketing approvals from the National Medical Products Administration (NMPA) for two of its innovative products: the coronary hypertension balloon dilation catheter wing extension and the microcatheter Vericor-RS. The coronary…
•
Acotec Scientific Holdings Ltd (HKG: 6669), a China-based medical device company, has announced that it has received marketing approval from the National Medical Products Administration (NMPA) for its innovative peripheral scoring balloon dilation catheter, Peridge. This device is designed for the treatment of occlusive lesions in autologous or synthetic arteriovenous…
•
Acotec Scientific Holdings Ltd (HKG: 6669), based in China, has received Investigational Device Exemption (IDE) approval from the U.S. FDA for its AcoArt Litos paclitaxel-coated percutaneous transluminal angioplasty (PTA) balloon catheter. This IDE approval enables Acotec to commence clinical trials for the device, pending Institutional Review Board (IRB) clearance. The…
•
Acotec Scientific Holdings Ltd (HKG: 6669), a China-based medical device company, has announced that it has received marketing approval from the Ministry of Health, Labour and Welfare of Japan for its peripheral support catheter, Vericor. This approval allows the product to be used in conjunction with a guide wire to…
•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced that it has received marketing approvals from the Ministry of Health, Labour and Welfare of Japan and the Thailand Food and Drug Administration for its Vericor-14 microcatheter. This regulatory clearance marks a significant milestone for the company’s product, which can now…
•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced a cooperation framework and service framework agreement with US firm Boston Scientific Group plc (BSG, NYSE: BSX), outlining a series of collaborations on global commercialization, product manufacturing service, product research and development (R&D), and other areas over the next three years.…
•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced a memorandum of understanding (MoU) with US firm Boston Scientific Group plc (BSG, NYSE: BSX), signaling their intention to explore collaboration in multiple fields, including research and development (R&D), manufacturing, and marketing and sales. Financial details of the agreement were not…
•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving marketing approval from the National Medical Products Administration (NMPA) for its Vericor-14 microcatheter. The product is now approved for use in percutaneous intervention surgery of coronary arteries and peripheral blood vessels, providing targeted access to the lesion site of narrow…
•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving marketing approval from the National Medical Products Administration (NMPA) for its paclitaxel-coated arteriovenous fistula high-pressure balloon dilation catheter, ACOART AVENS. The product is intended for use in percutaneous transluminal angioplasty (PTA) for autologous arteriovenous fistula stenosis in hemodialysis patients. Product…
•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving marketing approval from the National Medical Products Administration (NMPA) for its second-generation AcoStream, a product designed to remove blood clots in the peripheral vascular system. Advancement in Blood Clot Removal TechnologyThe first-generation version of AcoStream was approved for marketing in…
•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced that it has received marketing approval for its Vericor peripheral support catheter from the Thailand Food and Drug Administration. This development marks a significant step for the company as it expands the reach of its medical devices in the Southeast Asian…
•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving market approvals from the National Medical Products Administration (NMPA) for its products YAN and P-Conic balloon. These approvals mark significant milestones in the company’s product development and market expansion efforts. Product Details and ApplicationsYAN is a product designed to expand…
•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) has announced receiving market approval from the National Medical Products Administration (NMPA) for its intracranial PTA balloon NEO-Skater, designed to improve blood flow perfusion in atherosclerotic intracranial vessels. NEO-Skater: Innovative Design and BenefitsNEO-Skater features an improved lubrication coating on the catheter platform and…
•
China-based Acotec Scientific Holdings Ltd (HKG: 6669) and US major Boston Scientific Corporation (NYSE: BSX) entered into a partial acquisition offer and collaboration agreement. According to the offer, Boston Scientific will acquire up to 203.7 million of Acotec’s shares at HKD 20 (USD 2.57) apiece, amounting to a 65% stake.…